DK1290160T3 - Humane Pellino-polypeptider - Google Patents

Humane Pellino-polypeptider

Info

Publication number
DK1290160T3
DK1290160T3 DK01932711T DK01932711T DK1290160T3 DK 1290160 T3 DK1290160 T3 DK 1290160T3 DK 01932711 T DK01932711 T DK 01932711T DK 01932711 T DK01932711 T DK 01932711T DK 1290160 T3 DK1290160 T3 DK 1290160T3
Authority
DK
Denmark
Prior art keywords
polypeptides
pellino polypeptides
human pellino
well
human
Prior art date
Application number
DK01932711T
Other languages
English (en)
Inventor
Timothy A Bird
David J Cosman
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DK1290160T3 publication Critical patent/DK1290160T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01932711T 2000-04-28 2001-04-27 Humane Pellino-polypeptider DK1290160T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20019800P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
DK1290160T3 true DK1290160T3 (da) 2006-07-31

Family

ID=22740715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01932711T DK1290160T3 (da) 2000-04-28 2001-04-27 Humane Pellino-polypeptider

Country Status (10)

Country Link
US (3) US7169891B2 (da)
EP (1) EP1290160B1 (da)
AT (1) ATE321853T1 (da)
AU (1) AU2001259217A1 (da)
CY (1) CY1105555T1 (da)
DE (1) DE60118359T2 (da)
DK (1) DK1290160T3 (da)
ES (1) ES2261412T3 (da)
PT (1) PT1290160E (da)
WO (1) WO2001083739A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290160B1 (en) * 2000-04-28 2006-03-29 Immunex Corporation Human pellino polypeptides
US7250507B2 (en) * 2000-04-28 2007-07-31 Immunex Corporation Inhibitory Pellino nucleic acids
WO2002059611A2 (en) * 2001-01-02 2002-08-01 Tularik Inc. Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
US8703146B2 (en) * 2001-04-20 2014-04-22 Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
WO2002085933A1 (en) * 2001-04-20 2002-10-31 The Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
IL160837A0 (en) * 2001-10-05 2004-08-31 Coley Pharm Gmbh Toll-like receptor 3 signaling agonists and antagonists
US7348418B2 (en) * 2002-02-08 2008-03-25 Memorial Sloan-Kettering Cancer Center Carcinoma-related genes and polypeptides and methods of use thereof
WO2004031242A2 (en) * 2002-09-12 2004-04-15 Cellzome Ag Protein complexes involved in neurological diseases
EP1786908B1 (en) * 2004-08-18 2010-03-03 Bayer CropScience AG Plants with increased plastidic activity of r3 starch-phosphorylating enzyme
WO2008121349A1 (en) * 2007-03-29 2008-10-09 University Of Delaware Tag and target delivery system
WO2009143987A1 (en) * 2008-05-26 2009-12-03 National University Of Ireland, Maynooth Viral encoded pellino protein and its uses
GB201223114D0 (en) * 2012-12-21 2013-02-06 Nat Univ Ireland Novel peptide
GB201309509D0 (en) * 2013-05-28 2013-07-10 Nat Univ Ireland Diagnostic marker for crohn's disease
EP3191192B1 (en) * 2014-09-12 2019-11-06 The Procter and Gamble Company Method of making a skin care composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4018100A (en) 1999-03-26 2000-10-16 Human Genome Sciences, Inc. 49 human secreted proteins
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
WO2001009318A1 (fr) 1999-07-29 2001-02-08 Helix Research Institute Genes associes au cancer du foie
EP1290160B1 (en) 2000-04-28 2006-03-29 Immunex Corporation Human pellino polypeptides
US7250507B2 (en) * 2000-04-28 2007-07-31 Immunex Corporation Inhibitory Pellino nucleic acids
WO2002021138A2 (de) 2000-09-07 2002-03-14 Axaron Bioscience Ag Die m30-genfamilie und ihre verwendung
WO2002059611A2 (en) * 2001-01-02 2002-08-01 Tularik Inc. Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
US20040005615A1 (en) * 2002-05-24 2004-01-08 Jing Li Amplification and overexpression of oncogenes

Also Published As

Publication number Publication date
AU2001259217A1 (en) 2001-11-12
EP1290160B1 (en) 2006-03-29
WO2001083739A3 (en) 2002-12-19
US20040034199A1 (en) 2004-02-19
DE60118359D1 (de) 2006-05-18
US6703487B2 (en) 2004-03-09
US20020168683A1 (en) 2002-11-14
ATE321853T1 (de) 2006-04-15
EP1290160A2 (en) 2003-03-12
WO2001083739A2 (en) 2001-11-08
ES2261412T3 (es) 2006-11-16
US20070264711A1 (en) 2007-11-15
PT1290160E (pt) 2006-07-31
CY1105555T1 (el) 2010-07-28
US7169891B2 (en) 2007-01-30
DE60118359T2 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
MX2021011687A (es) Composiciones inmunogenicas y vacunas que comprenden peptidos y proteinas del virus de la peste porcina africana y usos de las mismas.
WO2001064835A8 (en) Novel nucleic acids and polypeptides
CY1105555T1 (el) Ανθρωπινα πολυπεπτιδια pellino
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
CY1116506T1 (el) Αντισωματα εναντι masp-2
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
BR0113286A (pt) Pirazóis substituìdos
PT1411908E (pt) Tratamento de infeccoes da unha com no
MXPA02004666A (es) Gelatinas recombinantes.
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
EA200201214A1 (ru) Замещенные тиоацетамиды
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
CY1109207T1 (el) Διαδικασια εχινοκανδινης
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
ATE429929T1 (de) Verbesserte impfstoffe
ATE398630T1 (de) Zyklische conotoxin-peptide
DK1294747T3 (da) Syntetiske fremgangsmåder for aplidine og nye antitumorale derivater, fremgangsmåder til fremstilling og anvendelse deraf
WO2001064834A8 (en) Novel nucleic acids and polypeptides
MXPA05005202A (es) Vacuna.
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2004053092A3 (en) Human pellino polypeptides
ATE473756T1 (de) Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
UA84831C2 (ru) Производные фактора коагуляции vii
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form